Erana, Sabeniana L.
HRN: 22-68-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2023
CEFAZOLIN 1GM (VIAL)
03/20/2023
03/21/2023
IV
1gm
Q8H X 3 Doses
S/P Vaginal Hysterectomy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes